0001209191-20-050873.txt : 20200917
0001209191-20-050873.hdr.sgml : 20200917
20200917161200
ACCESSION NUMBER: 0001209191-20-050873
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200915
FILED AS OF DATE: 20200917
DATE AS OF CHANGE: 20200917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sebelius Kathleen
CENTRAL INDEX KEY: 0001654316
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37929
FILM NUMBER: 201181331
MAIL ADDRESS:
STREET 1: C/O DERMIRA, INC.
STREET 2: 275 MIDDLEFIELD ROAD, SUITE 150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Myovant Sciences Ltd.
CENTRAL INDEX KEY: 0001679082
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: CA
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: SUITE 1, 3RD FLOOR
STREET 2: 11-12 ST. JAMES SQUARE
CITY: LONDON
STATE: X0
ZIP: SW1Y 4LB
BUSINESS PHONE: 44 207-400-3351
MAIL ADDRESS:
STREET 1: SUITE 1, 3RD FLOOR
STREET 2: 11-12 ST. JAMES SQUARE
CITY: LONDON
STATE: X0
ZIP: SW1Y 4LB
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-15
0
0001679082
Myovant Sciences Ltd.
MYOV
0001654316
Sebelius Kathleen
C/O MYOVANT SCIENCES INC.
2000 SIERRA POINT PARKWAY
BRISBANE
CA
94005
1
0
0
0
Stock Option (Right to Buy)
21.47
2020-09-15
4
A
0
21603
0.00
A
2030-09-14
Common Shares
21603
21603
D
100% of the shares underlying the option vest and become exercisable on the earlier of (a) September 15, 2021, and (b) the date that is one day prior to the Issuer's 2021 Annual General Meeting of Shareholders, subject to the Reporting Person providing continuous service to the Issuer on such date.
/s/ Matthew Lang, Attorney-in-fact
2020-09-17